Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP Print Edition

JHOP Weekly e‑Newsletter

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.

Original Article

Comparing the Efficacy and Safety of Reference Drug Filgrastim and Biosimilar Filgrastim-sndz in Pediatric Patients Used for Post–Hematopoietic Stem-Cell Transplant Engraftment or Chemotherapy-Induced Febrile Neutropenia Prophylaxis

Cassandra Rush, PharmD; Ashley Sabus, PharmD, BCOP; Obehi Enabulele, PharmD, MBA, MS; Abby Kim, BA, PharmD, BCOP

Dosing of 3 Targeted Agents in Novel Drug Combinations Used at the Precision Medicine Clinic of the University of California San Diego

Mina Nikanjam, MD, PhD; Jose Tinajero, PharmD; Mary McGann, PharmD, BCOP; Jerry Li, PharmD; Jincheng Yang, PharmD; Felicity Shen, PharmD; Jason K. Sicklick, MD; Shumei Kato, MD; Edmund Capparelli, PharmD; Razelle Kurzrock, MD

Economic Burden of Cardiovascular Events in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the First Year After Initiating Treatment with a Novel Agent

Elisabetta Malangone-Monaco, DrPH; Kellie Ryan, MPH; Elizabeth H. Marchlewicz, PhD, MPH, RD; Joyce Lo, PharmD; Scott Huntington, MD, MPH

Incidence of Hypothyroidism in Patients with Cancer Receiving Immune Checkpoint Inhibitors

Nada Alsuhebany, BSPharm, PharmD, BCOP; Anastasia Graham, PharmD, MBA, BCOP; Erin Weeda, PharmD, BCPS; Amy Sion, PharmD, BCOP

Assessment of the Elimination of Test Doses for Paclitaxel and Carboplatin in Patients with Cancer

Colleen McCann, PharmD; Aaron Steele, PharmD, BCOP

Outcomes and Adverse Events Linked to Off-Label Treatment of Solid Tumors with PARP Inhibitors

Bestis Wasef, PharmD, BCOP; Kelly Fritz, PharmD, BCOP; Courtney C. Cavalieri, PharmD, BCOP

Impact of Pharmacist Telephone Follow-Up on Chemotherapy-Induced Nausea and Vomiting

Jenny McCabe, PharmD; Amanda Al-Bahou, PharmD, BCOP; Leann Koontz, PharmD, BCPS, BCOP; Linda Linderbeck, PharmD, BCOP; Michael Verbosky, PharmD, BCPS; Michelle Prieto, PharmD

Evaluating Institutional Safety Standards Related to Continuing Oral Antineoplastic Medication Use During Hospitalization

Belinda Li, PharmD, BCOP; Laura Beth Parsons, PharmD, BCOP; Darby Siler, PharmD, BCOP; Rachel Matthews, PharmD, BCOP

Time to First Palbociclib Prescription Dispense at Mayo Clinic: Comparing a Health-System Specialty Pharmacy with External Specialty Pharmacies

Allison P. Golbach, PharmD; Jodi L. Taraba, PharmD; Matthew D. Smith, PharmD; Kristin C. Mara, MS; Karthik V. Giridhar, MD

Comparing the Impact of Abiraterone and Enzalutamide Sequencing on Progression-Free Survival in Veterans with Metastatic Castration-Resistant Prostate Cancer

Nicholas J. Newman, PharmD; Sara E. Gordon, PharmD, BCOP; Charles J. Nock, MD; Christopher J. Burant, PhD; Candice M. Wenzell, PharmD, BCOP

Page 1 of 11
Results 1 - 10 of 110